AmerisourceBergen Co. (NYSE:ABC) Shares Sold by National Pension Service

National Pension Service trimmed its position in AmerisourceBergen Co. (NYSE:ABC – Get Rating) by 1.8% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 259,105 shares of the company’s stock after selling 4,695 shares during the quarter. National Pension Service’s holdings in AmerisourceBergen were worth $35,256,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of AmerisourceBergen by 1.5% during the 3rd quarter. Vanguard Group Inc. now owns 19,220,144 shares of the company’s stock worth $2,601,062,000 after purchasing an additional 292,173 shares during the last quarter. State Street Corp boosted its holdings in shares of AmerisourceBergen by 2.4% during the 3rd quarter. State Street Corp now owns 6,990,466 shares of the company’s stock worth $946,020,000 after purchasing an additional 165,682 shares during the last quarter. FMR LLC boosted its holdings in shares of AmerisourceBergen by 10.2% during the 2nd quarter. FMR LLC now owns 5,664,668 shares of the company’s stock worth $801,436,000 after purchasing an additional 523,003 shares during the last quarter. Boston Partners boosted its holdings in shares of AmerisourceBergen by 11.4% during the 3rd quarter. Boston Partners now owns 5,041,639 shares of the company’s stock worth $684,631,000 after purchasing an additional 514,462 shares during the last quarter. Finally, Invesco Ltd. raised its position in shares of AmerisourceBergen by 42.3% during the 1st quarter. Invesco Ltd. now owns 2,079,491 shares of the company’s stock valued at $321,717,000 after buying an additional 618,248 shares during the period. 84.79% of the stock is currently owned by institutional investors and hedge funds.

AmerisourceBergen Stock Performance

NYSE:ABC opened at $152.05 on Friday. The company has a fifty day simple moving average of $159.12 and a two-hundred day simple moving average of $155.96. The company has a market cap of $30.75 billion, a price-to-earnings ratio of 18.45, a price-to-earnings-growth ratio of 1.46 and a beta of 0.54. The company has a quick ratio of 0.53, a current ratio of 0.91 and a debt-to-equity ratio of 63.30. AmerisourceBergen Co. has a 52 week low of $135.14 and a 52 week high of $174.63.

AmerisourceBergen (NYSE:ABC – Get Rating) last posted its quarterly earnings results on Wednesday, February 1st. The company reported $2.71 EPS for the quarter, topping the consensus estimate of $2.62 by $0.09. The business had revenue of $62.85 billion during the quarter, compared to the consensus estimate of $62.77 billion. AmerisourceBergen had a net margin of 0.72% and a return on equity of 597.57%. The company’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.58 earnings per share. As a group, equities analysts anticipate that AmerisourceBergen Co. will post 11.61 earnings per share for the current fiscal year.

AmerisourceBergen Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 27th. Shareholders of record on Friday, February 10th were paid a $0.485 dividend. The ex-dividend date was Thursday, February 9th. This represents a $1.94 annualized dividend and a dividend yield of 1.28%. AmerisourceBergen’s dividend payout ratio (DPR) is 23.54%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Evercore ISI reaffirmed an “outperform” rating and set a $185.00 price target on shares of AmerisourceBergen in a research report on Tuesday, January 31st. Mizuho lifted their price target on shares of AmerisourceBergen from $162.00 to $170.00 and gave the company a “neutral” rating in a research report on Thursday, February 2nd. Robert W. Baird lifted their price target on shares of AmerisourceBergen from $199.00 to $201.00 and gave the company an “outperform” rating in a research report on Thursday, February 2nd. Credit Suisse Group lifted their price target on shares of AmerisourceBergen from $175.00 to $182.00 and gave the company an “outperform” rating in a research report on Tuesday, November 22nd. Finally, UBS Group lifted their price target on shares of AmerisourceBergen from $184.00 to $190.00 and gave the company a “buy” rating in a research report on Tuesday, January 31st. Two equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $180.08.

Insiders Place Their Bets

In related news, CEO Steven H. Collis sold 10,499 shares of the business’s stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $150.00, for a total transaction of $1,574,850.00. Following the completion of the transaction, the chief executive officer now owns 257,967 shares in the company, valued at $38,695,050. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, CEO Steven H. Collis sold 10,499 shares of the business’s stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $150.00, for a total transaction of $1,574,850.00. Following the completion of the transaction, the chief executive officer now owns 257,967 shares in the company, valued at $38,695,050. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Lazarus Krikorian sold 2,218 shares of the business’s stock in a transaction on Wednesday, December 21st. The stock was sold at an average price of $169.24, for a total transaction of $375,374.32. Following the transaction, the chief accounting officer now owns 20,007 shares of the company’s stock, valued at approximately $3,385,984.68. The disclosure for this sale can be found here. Insiders sold a total of 30,851 shares of company stock worth $4,865,455 over the last 90 days. Corporate insiders own 20.10% of the company’s stock.

About AmerisourceBergen

(Get Rating)

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies.